These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 14582672)

  • 1. Neurotrophins and their role in pathogenesis of alopecia areata.
    Botchkarev VA
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):195-8. PubMed ID: 14582672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata.
    Ito T
    Clin Dev Immunol; 2013; 2013():348546. PubMed ID: 24151515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-deficient C3.MRL-Tnfrsf6(lpr) mice and Fas ligand-deficient C3H/HeJ-Tnfsf6(gld) mice are relatively resistant to the induction of alopecia areata by grafting of alopecia areata-affected skin from C3H/HeJ mice.
    Freyschmidt-Paul P; McElwee KJ; Botchkarev V; Kissling S; Wenzel E; Sundberg JP; Happle R; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):104-8. PubMed ID: 12895005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata).
    Siebenhaar F; Sharov AA; Peters EM; Sharova TY; Syska W; Mardaryev AN; Freyschmidt-Paul P; Sundberg JP; Maurer M; Botchkarev VA
    J Invest Dermatol; 2007 Jun; 127(6):1489-97. PubMed ID: 17273166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response.
    Tobin DJ
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):176-81. PubMed ID: 14582669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalisation of hair follicle morphology in C3H/HeJ alopecia areata mice after treatment with squaric acid dibutylester.
    Gardner S; Freyschmidt-Paul P; Hoffmann R; Sundberg JP; Happle R; Lindsey NJ; Tobin DJ
    Eur J Dermatol; 2000 Aug; 10(6):443-50. PubMed ID: 10980465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb?
    Paus R; Slominski A; Czarnetzki BM
    Yale J Biol Med; 1993; 66(6):541-54. PubMed ID: 7716973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alopecia areata: a tissue specific autoimmune disease of the hair follicle.
    Gilhar A; Kalish RS
    Autoimmun Rev; 2006 Jan; 5(1):64-9. PubMed ID: 16338213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of neurogenic inflammation in the pathogenesis of alopecia areata.
    Shi Y; Wan S; Song X
    J Dermatol; 2024 May; 51(5):621-631. PubMed ID: 38605467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial growth control by neurotrophins: leads and lessons from the hair follicle.
    Botchkarev VA; Botchkareva NV; Peters EM; Paus R
    Prog Brain Res; 2004; 146():493-513. PubMed ID: 14699982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alopecia areata: What's new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
    Dainichi T; Kabashima K
    J Dermatol Sci; 2017 Apr; 86(1):3-12. PubMed ID: 27765435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alopecia areata: more than skin deep.
    MacLean KJ; Tidman MJ
    Practitioner; 2013 Sep; 257(1764):29-32, 3. PubMed ID: 24383154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of alopecia areata.
    Hordinsky MK
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S13-5. PubMed ID: 24326541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for Alopecia Areata in Mice by Stimulating the Hair Cycle with Parathyroid Hormone Agonists Linked to a Collagen-Binding Domain.
    Katikaneni R; Seymour AW; Gulati R; Ponnapakkam T; Gensure RC
    J Investig Dermatol Symp Proc; 2015 Nov; 17(2):13-5. PubMed ID: 26551937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alopecia areata update.
    Alkhalifah A
    Dermatol Clin; 2013 Jan; 31(1):93-108. PubMed ID: 23159179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata.
    Amoh Y; Maejima H; Niiyama S; Mii S; Hamada Y; Saito N; Katsuoka K
    Eur J Dermatol; 2011; 21(2):209-12. PubMed ID: 21524985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alopecia areata susceptibility in rodent models.
    McElwee KJ; Freyschmidt-Paul P; Zöller M; Hoffmann R
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):182-7. PubMed ID: 14582670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study.
    Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A
    Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
    Carroll JM; McElwee KJ; E King L; Byrne MC; Sundberg JP
    J Invest Dermatol; 2002 Aug; 119(2):392-402. PubMed ID: 12190862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis.
    Alkhalifah A; Alsantali A; Wang E; McElwee KJ; Shapiro J
    J Am Acad Dermatol; 2010 Feb; 62(2):177-88, quiz 189-90. PubMed ID: 20115945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.